title: Regulation, manufacturing and building industry consensus.
abstract: As has been true with many emerging technologies, successful clinical development and recruitment of capital sufficient to reach market approval is measured as an industry platform. Risk, failure and achievement by individual companies are shared by all in the context of access to enthusiastic capital markets and codevelopment partnerships.
authors.affiliation: Athersys Inc., 3201 Carnegie Avenue, Cleveland, OH 44115-2634, USA.
authors.forename: Robert
authors.initials: R
authors.lastname: Deans
mesh_terms: D032921:Consensus; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D018380:Hematopoietic Stem Cell Transplantation / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence / Q000458:organization & administration; D012926:Social Control, Formal